Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
West Pharmaceutical Services, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $4.11B | $4.03B - $4.19B | $1.13B | $12.437 | 7 |
| Dec 2029 | $4.05B | $3.98B - $4.14B | $1.11B | $12.264 | 7 |
| Dec 2028 | $3.77B | $3.76B - $3.78B | $1.03B | $10.706 | 8 |
| Dec 2027 | $3.53B | $3.46B - $3.60B | $967.26M | $9.558 | 11 |
| Dec 2026 | $3.33B | $3.26B - $3.36B | $911.94M | $8.611 | 12 |
| Dec 2025 | $3.06B | $3.01B - $3.07B | $839.12M | $7.095 | 11 |
| Dec 2024 | $2.88B | $2.83B - $2.89B | $790.10M | $6.631 | 8 |
| Dec 2023 | $2.88B | $2.82B - $2.94B | $787.93M | $7.117 | 7 |
| Dec 2022 | $2.84B | $2.81B - $2.87B | $817.30M | $8.173 | 2 |
| Dec 2021 | $2.81B | $2.79B - $2.84B | $685.73M | $8.491 | 3 |
| Dec 2020 | $2.10B | $2.08B - $2.13B | $410.38M | $4.54 | 5 |
| Dec 2019 | $1.82B | $1.81B - $1.84B | $348.84M | $3.141 | 2 |